What the US Food and Drug Administration has cleared, approved and recalled on this topic, and the side effects people report.
Each number has its full source under its own list below.
4 recalls (since 1 Jan 2023). Recalls of medicines for this topic, newest first.
Reason: CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
Reason: Failed Impurities/Degradation Specifications: Related Substances
Reason: CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
Reason: CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
Source: openFDA, Drug recall enforcement reports, since 1 Jan 2023. Retrieved 12 Nov 2026.
12 recalls (since 1 Jan 2023). Recalls of medical devices for this topic, newest first.
Reason: The device may be unable to correctly format its internal memory. When the internal memory cannot be correctly formatted, previously recorded studies may remain on the device and may be updated with…
Reason: Extra small (ES) and Extra-large (XL) infant sleep sacks have not been reviewed for safety and effectiveness by the FDA.
Reason: Extra small (ES) and Extra-large (XL) infant sleep sacks have not been reviewed for safety and effectiveness by the FDA.
Reason: Products are labeled with incorrect Use By Date, extending beyond the validated three-year shelf life from date of manufacturer. Material degradation of a product past its Use By Date may result in u…
Reason: Due to device not having FDA Clearance
Reason: Due to firm mistakenly distributing product within the U.S. without FDA premarket clearance/approval.
Reason: Due to misaligned V-Lock feature on the Mobile Power Unit power cords, which prevents the locking mechanism from properly engaging with the Mobile Power Unit and may cause unintended disconnect.
Reason: Due to misaligned V-Lock feature on the Mobile Power Unit power cords, which prevents the locking mechanism from properly engaging with the Mobile Power Unit and may cause unintended disconnect.
Reason: This recall is retroactively being reported. Refurbished bassinets failed to meet quality standards prior to distribution.
Reason: Natus has become aware that its third-party supplier Parker Laboratories Inc. is conducting a voluntary recall related to their Tensive Conductive Adhesive Gel, Ref. 22-60 Lot Number A0623009. They h…
Source: openFDA, Medical device recalls, since 1 Jan 2023. Retrieved 12 Nov 2026.
38 devices cleared (since 1 Jan 2023). Devices the FDA cleared to sell in the US, newest first.
Company: Neurotronics, LLC
Company: Ram.Shaw Pte., Ltd.
Company: Samsung Electronics Co., Ltd.
Company: Vivaquant, Inc. Dba Rhythm Express
Company: Endeavor Commerce, LLC
Company: Koncept Innovators, Inc.
Company: Onera B.V.
Company: Ram.Shaw Pte. , Ltd.
Company: Sleepiz AG
Source: openFDA, Premarket notifications (510(k)) cleared, since 1 Jan 2023. Retrieved 12 Nov 2026.
14,022 side effect reports (reports received since 1 Jan 2023). The reactions named most often in reports about medicines used for this topic.
Anyone can send a report. A report does not prove that the medicine caused the reaction, and the counts do not show how often it happens.
Source: openFDA, FDA Adverse Event Reporting System (FAERS), reports by reaction, reports received since 1 Jan 2023. Retrieved 12 Nov 2026.
Worldwide · 2024–2034
View report Digital HealthWorldwide · 2024–2034
View report Medical DevicesWorldwide · 2024–2034
View report PharmaceuticalsWorldwide · 2024–2034
View report OTC & NutraceuticalsWorldwide · 2024–2034
View report Digital HealthWorldwide · 2024–2034
View report
170 WHO Member States report the use of traditional medicine. Adaptogens like ashwagandha, rhodiola and…
Read
Depression and anxiety cost the world about US$1 trillion a year. Ashwagandha has some evidence for stress…
Read
About 3 in 10 US adults sleep less than 7 hours. Melatonin helps with jet lag and shift work, but its effect…
ReadAcuitas market sizes and forecasts are only in our full reports. How we use public data.